You are using an older browser version. Please use a supported version for the best MSN experience.

ZOSANO PHARMA CORPORATION

NASDAQ: ZSAN
1.21
+0.16
+15.24%
Operating Income
-37.20M
Operating Margin
-
Total Equity
-
Retained Earnings
-
Free Cashflow
-
Price/Cashflow
-
  • Income Statement
  • Balance Sheet
  • Cash Flow
  • Annual
  • Quarterly
  • Values in Millions (Except for per share items)

  • 2016

  • 2017

  • 2018

  • 2019

    • Period End Date

    • 12/31/2016

    • 12/31/2017

    • 12/31/2018

    • 12/31/2019

    • Stmt Source

    • Annual

    • Annual

    • Annual

    • Annual

    • Stmt Source Date

    • 12/31/2016

    • 12/31/2017

    • 12/31/2018

    • 12/31/2019

    • Stmt Update Type

    • -

    • -

    • -

    • -

    • Currency Code

    • Total Revenue

    • 0.0

    • 0.0

    • 0.0

    • 0.0

    • Cost of Revenue

    • -

    • -

    • -

    • -

    • Gross Profit

    • -

    • -

    • -

    • -

    • Selling,General and Administrative

    • 8.2

    • 8.2

    • 9.4

    • 11.8

    • Research and Development

    • 20.5

    • 20.2

    • 25.5

    • 25.4

    • Special Income/Charges

    • 0.0

    • -

    • -0.5

    • 0.0

    • Operating Expenses

    • 28.6

    • 28.4

    • 35.4

    • 37.2

    • Operating Income

    • -28.6

    • -28.4

    • -35.4

    • -37.2

    • Net Interest Income

    • 0.0

    • 0.0

    • 0.0

    • -0.1

    • Other Income/Expense,Net

    • 0.0

    • 0.0

    • 0.0

    • -0.1

    • Pre-Tax Income

    • -29.8

    • -29.1

    • -35.4

    • -37.6

    • Provision for Income Tax

    • -

    • -

    • -

    • -

    • Net Income

    • -29.8

    • -29.1

    • -35.4

    • -37.6

    • Dividend Per Share

    • -

    • -

    • -

    • -

    • Tax Rate

    • Basic EPS

    • -43.32

    • -16.82

    • -3.74

    • -2.29

    • Diluted EPS

    • -43.32

    • -16.82

    • -3.74

    • -2.29

    AdChoices
    AdChoices
    AdChoices
    image beaconimage beaconimage beacon